Cargando…
Hydroxyurea pharmacokinetics and precision dosing in low-resource settings
Introduction: Hydroxyurea is effective disease-modifying treatment for sickle cell anemia (SCA). Escalation to maximum tolerated dose (MTD) achieves superior benefits without additional toxicities, but requires dose adjustments with serial monitoring. Pharmacokinetic (PK)-guided dosing can predict a...
Autores principales: | Smart, Luke R., Charles, Mwesige, McElhinney, Kathryn E., Dong, Min, Power-Hays, Alexandra, Howard, Thad, Vinks, Alexander A., Ambrose, Emmanuela E., Ware, Russell E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267409/ https://www.ncbi.nlm.nih.gov/pubmed/37325474 http://dx.doi.org/10.3389/fmolb.2023.1130206 |
Ejemplares similares
-
O-12: BUILDING LOCAL CAPACITY FOR HYDROXYUREA PHARMACOKINETICS AND PRECISION DOSING IN LOW-RESOURCE SETTINGS
por: L., SMART, et al.
Publicado: (2022) -
Surveillance for sickle cell disease, United Republic of Tanzania
por: Ambrose, Emmanuela E, et al.
Publicado: (2020) -
Ultra-High-Precision, in-vivo Pharmacokinetic Measurements Highlight the Need for and a Route Toward More Highly Personalized Medicine
por: Vieira, Philip A., et al.
Publicado: (2019) -
Electrochemical Determination of Hydroxyurea in a Complex Biological Matrix Using MoS(2)-Modified Electrodes and Chemometrics
por: Cazelles, Remi, et al.
Publicado: (2020) -
High-throughput quantitation of amino acids and acylcarnitine in cerebrospinal fluid: identification of PCNSL biomarkers and potential metabolic messengers
por: Ma, Jingjing, et al.
Publicado: (2023)